BSX Boston Scientific Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NYSE: BSX
  4. Earnings

EPS in 2025 (TTM): $1.7

Last Report Period Date: Jun 30, 2025

Currently, BSX's 12-month EPS stands at $1.7, according to the most recent financial reports. Boston Scientific's earnings per share in 2024 was reported at $1.26, marking a rise from $1.08 in 2023. BSX recorded an EPS of $0.54 for the quarterly period ending on Jun 30, 2025.

BSX earnings history

Historical annual and quarterly earnings per share (EPS) data for Boston Scientific
EPS (TTM)
$1.7
EPS Growth YoY (Quarterly)
145.5%
EPS (Quarterly)
$0.54
EPS Growth (Quarterly)
17.4%

In 2024, Boston Scientific's earnings per share was $1.26, a rise of 16.7% from $1.08 in 2023. The quarterly earnings per share for the period ending Jun 30, 2025, was $0.54, showing a 145.5% increase compared to the same quarter last year. The trailing twelve months EPS for BSX is $1.7 as of June 2025. Boston Scientific's full-year EPS for 2023 was $1.08, a 140% rise compared to the previous year.

BSX EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
145.5%
EPS growth YoY
16.7%
EPS growth 3Y avg
22.2%
EPS growth 5Y avg
-17.9%

Over the past 12 months, Boston Scientific has recorded an earnings per share growth rate of 145.5% (YoY, quarterly). Over an extended period, the company recorded an average EPS annual growth rate of 22.2% per year for the last 3 years. In the last five years, the company had an average annual EPS growth of -17.9%.

BSX Earnings Waterfall

Breakdown of revenue, profit and net income for Boston Scientific

BSX Earnings vs Peers

What are the earnings of BSX compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
EW Edwards Lifesciences Corp 11.15 202.2% 42.5% 33%
CNMD CONMED Corp 14.99 104.3% 26.1% 33.5%
MDT Medtronic plc 25.13 31% -1.1% 0.3%
TFX Teleflex Inc 26.67 -80.3% -47.6% -31.7%
MMSI Merit Medical Systems Inc 42.19 26.2% 34% 83.3%
SYK Stryker Corp 49.2 -5.8% 14.1% 7.1%
BSX Boston Scientific Corp 60.56 16.7% 22.2% -17.9%
ANGO Angiodynamics Inc N/A 81.9% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.